|
BLMH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.743800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.169400E-01 |
| Normal-vs-Stage2 |
1.963780E-03 |
| Normal-vs-Stage3 |
1.192980E-01 |
| Normal-vs-Stage4 |
3.665600E-02 |
| Stage1-vs-Stage2 |
5.774400E-04 |
| Stage1-vs-Stage3 |
4.770300E-02 |
| Stage1-vs-Stage4 |
1.334370E-02 |
| Stage2-vs-Stage3 |
2.49569999999366E-05 |
| Stage2-vs-Stage4 |
1.94833999999089E-05 |
| Stage3-vs-Stage4 |
5.612800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.556400E-01 |
| Normal-vs-AfricanAmerican |
5.354800E-01 |
| Normal-vs-Asian |
4.695400E-01 |
| Caucasian-vs-AfricanAmerican |
1.993360E-01 |
| Caucasian-vs-Asian |
9.380400E-01 |
| AfricanAmerican-vs-Asian |
2.730200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.478400E-01 |
| Normal-vs-Female |
8.446600E-01 |
| Male-vs-Female |
5.587200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.370000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.861600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.068200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.483200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.031200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.034000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.834800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.695700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.962600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.485200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.361960E-04 |
| Classical-VS-Follicular |
1.88649999954826E-07 |
| Classical-VS-Other |
4.965600E-01 |
| Classical-VS-Normal |
3.242800E-01 |
| Tall-VS-Follicular |
2.37520003665281E-11 |
| Tall-VS-Other |
2.482000E-01 |
| Tall-VS-Normal |
2.49729999999282E-05 |
| Follicular-VS-Other |
3.220200E-02 |
| Follicular-VS-Normal |
5.98680000000185E-05 |
| Other-VS-Normal |
1.966430E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.234200E-02 |
| Normal-vs-N1 |
4.389300E-04 |
| N0-vs-N1 |
1.20050000051997E-07 |
|
|
